Yulia Maxuitenko
Impact in
- Pharmacology top 10%
- Inflammatory mediators and NSAID effects
Papers in
-
- Phosphodiesterase function and regulation 6
- Genomics, phytochemicals, and oxidative stress 5
- Oncology 17
- Peptidase Inhibition and Analysis 6
- HER2/EGFR in Cancer Research 4
- Co-authors
- Bill D. Roebuck (5 shared papers)Gary A. Piazza (26 shared papers)Adam B. Keeton (25 shared papers)Thomas W. Kensler (3 shared papers)Heather N. Tinsley (3 shared papers)Bernard D. Gary (3 shared papers)Yonghe Li (2 shared papers)Jose Thaiparambil (2 shared papers)
- Journals
- Cancer Research (10 papers)Journal of Clinical Oncology (4 papers)Cancer Chemotherapy and Pharmacology (3 papers)Cancers (3 papers)Carcinogenesis (2 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Yulia Maxuitenko
43 papers receiving 844 citations
Peers
Comparison fields: 5 of 84
- Pharmacology 139
- Cancer Research 117
- Molecular Biology 481
- Biochemistry 50
- Toxicology 22
Countries citing papers authored by Yulia Maxuitenko
This map shows the geographic impact of Yulia Maxuitenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yulia Maxuitenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yulia Maxuitenko more than expected).
Fields of papers citing papers by Yulia Maxuitenko
This network shows the impact of papers produced by Yulia Maxuitenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yulia Maxuitenko. The network helps show where Yulia Maxuitenko may publish in the future.
Co-authors
The 25 scholars most cited alongside Yulia Maxuitenko, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Transient intervention with oltipraz protects against aflatoxin-induced hepatic tumorigenesis. | 1993 | 82 |
| 2 | 2009 | 80 | |
| 3 | 2010 | 78 | |
| 4 | 2006 | 72 | |
| 5 | 1998 | 68 | |
| 6 | 2014 | 58 | |
| 7 | 1994 | 56 | |
| 8 | 2020 | 51 | |
| 9 | 2003 | 39 | |
| 10 | 2008 | 34 | |
| 11 | 1993 | 31 | |
| 12 | 2003 | 25 | |
| 13 | 1996 | 23 | |
| 14 | 2019 | 23 | |
| 15 | 2020 | 21 | |
| 16 | 2019 | 21 | |
| 17 | 2021 | 20 | |
| 18 | 2020 | 15 | |
| 19 | 1997 | 9 | |
| 20 | 2022 | 9 |
About Yulia Maxuitenko
Yulia Maxuitenko is a scholar working on Molecular Biology, Oncology, Pharmacology, Organic Chemistry and Genetics, having authored 48 papers that have together received 875 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (8 papers), Phosphodiesterase function and regulation (6 papers), Estrogen and related hormone effects (6 papers), Peptidase Inhibition and Analysis (6 papers), Synthesis and biological activity (6 papers), Genomics, phytochemicals, and oxidative stress (5 papers), Cancer Research and Treatments (5 papers) and HER2/EGFR in Cancer Research (4 papers). The work is most often cited by research in Pharmacology (139 citations), Cancer Research (117 citations), Molecular Biology (481 citations), Biochemistry (50 citations) and Toxicology (22 citations). Yulia Maxuitenko has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Bill D. Roebuck, Gary A. Piazza, Adam B. Keeton, Thomas W. Kensler, Heather N. Tinsley, Bernard D. Gary, Yonghe Li, Jose Thaiparambil, John D. Groopman and Lisa P. Jacobson. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Cancers and Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.